Replies to post #919 on ImmunoGen Inc (IMGN)

[skitahoe]

I believe that both will pay off nicely in the next several years unless they are bought out, and if they are, it will be at a substantial premium on the price at the time.

IMGN ought to end the year in the $20's or higher. NWBO could be anywhere between $1 and $20, depending on where they are with approvals from the four regulators they will approach when they have the production capability. For $20, they need the approval to use the EDEN unit for production and at least apply to the FDA. I believe that they will have UK approval by early fourth quarter, and that should be worth at least $3, but it is with manual production until the EDEN unit is approved.

Gary